MedPath

HVIVO SERVICES LIMITED

HVIVO SERVICES LIMITED logo
🇬🇧United Kingdom
Ownership
Private
Established
2007-01-01
Employees
51
Market Cap
-
Website
https://flucamp.com

Dose, Safety, and Pathogenicity of a New Influenza a H3N2 Challenge Strain

Not Applicable
Recruiting
Conditions
Influenza a H3N2
Interventions
Other: Influenza A H3N2 virus dose arm 1
Other: Influenza A H3N2 virus dose arm 2
Other: Influenza A H3N2 virus dose arm 3
First Posted Date
2024-09-26
Last Posted Date
2024-09-26
Lead Sponsor
Hvivo
Target Recruit Count
80
Registration Number
NCT06613737
Locations
🇬🇧

hVIVO Services Ltd, 40 Bank Street, London, United Kingdom

Dose, Safety and Pathogenicity of SARS-CoV-2 (COVID-19) Omicron Virus (BA.5)

Early Phase 1
Recruiting
Conditions
SARS-CoV-2 Infection
Interventions
Biological: SARS-CoV-2 omicron virus dose arm 3
Biological: SARS-CoV-2 omicron virus dose arm 2
Biological: SARS-CoV-2 omicron virus dose arm 1
First Posted Date
2024-07-09
Last Posted Date
2025-01-30
Lead Sponsor
Hvivo
Target Recruit Count
90
Registration Number
NCT06492564
Locations
🇬🇧

hVIVO Services Ltd, 40 Bank Street, Canary Wharf, London, United Kingdom

Dose, Safety, and Pathogenicity of a New Influenza B Strain

Phase 2
Recruiting
Conditions
Influenza B
Interventions
Biological: influenza B/Connecticut/1/21 virus part a dose arm 2
Biological: influenza B/Connecticut/1/21 virus part b dose 1
Biological: influenza B/Connecticut/1/21 virus part b dose 2
Biological: influenza B/Connecticut/1/21 virus part a dose arm 1
First Posted Date
2024-02-12
Last Posted Date
2024-02-12
Lead Sponsor
Hvivo
Target Recruit Count
60
Registration Number
NCT06254820
Locations
🇬🇧

QMB, London, United Kingdom

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Not Applicable
Completed
Conditions
Influenza A H1N1
Interventions
Other: Infectious Titre 1
Other: Infectious Titre 2
Other: Infectious Titre 3
Other: Infectious Titre 4
First Posted Date
2022-10-07
Last Posted Date
2023-09-13
Lead Sponsor
Hvivo
Target Recruit Count
70
Registration Number
NCT05572450
Locations
🇬🇧

hVIVO Services Ltd, London, United Kingdom

Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Phase 2
Completed
Conditions
Respiratory Syncytial Virus Infections
Interventions
Biological: RSVPreF
Other: Placebo
First Posted Date
2021-03-08
Last Posted Date
2024-08-07
Lead Sponsor
Hvivo
Target Recruit Count
70
Registration Number
NCT04785612
Locations
🇬🇧

Golam Kabir, London, United Kingdom

RSV Study in Adults 60 to 75 Years of Age

Not Applicable
Completed
Conditions
RSV Infection
Interventions
Other: Challenge virus RSV-A Memphis 37b
First Posted Date
2019-04-18
Last Posted Date
2019-10-14
Lead Sponsor
Hvivo
Target Recruit Count
24
Registration Number
NCT03919591
Locations
🇬🇧

hVIVO Services Limited, London, United Kingdom

Study Examining PrEP-001 in Subjects With Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
First Posted Date
2017-09-29
Last Posted Date
2017-09-29
Lead Sponsor
Hvivo
Target Recruit Count
60
Registration Number
NCT03296917

Study Examining PrEP-001 in Healthy Subjects

Phase 2
Completed
Conditions
Influenza A H3N2
Interventions
Other: Placebo Comparator
First Posted Date
2017-07-18
Last Posted Date
2019-11-12
Lead Sponsor
Hvivo
Target Recruit Count
66
Registration Number
NCT03220048
Locations
🇬🇧

hVIVO Services Ltd, QMB Bioenterprise building, London, United Kingdom

Influenza Challenge Study in Healthy Volunteers

Phase 1
Completed
Conditions
Influenza
Interventions
Biological: Low titre
Biological: Medium Low Titre Influenza virus
Biological: High Titre Influenza virus
Biological: Medium - High Influenza virus
First Posted Date
2016-04-21
Last Posted Date
2016-04-21
Lead Sponsor
Hvivo
Target Recruit Count
24
Registration Number
NCT02746211
Locations
🇬🇧

hVIVO Services Ltd, QMB Bioenterprise building, London, United Kingdom

Characterisation of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Not Applicable
Completed
Conditions
Influenza
Interventions
Other: Infectious titre 5 (H3N2) (Subjects aged 18 to 45 years old)
Other: Infectious titre 1 (H3N2)
Other: Infectious titre 4 (H3N2)
Other: Infectious titre 2 (H3N2)
Other: Infectious titre 3 (H3N2)
Other: Infectious titre 5 (H3N2) (Subjects aged 46 to 64 years old)
First Posted Date
2015-08-17
Last Posted Date
2020-01-27
Lead Sponsor
Hvivo
Target Recruit Count
46
Registration Number
NCT02525055
© Copyright 2025. All Rights Reserved by MedPath